Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Obstructive Lung Diseases

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 212 articles:
HTML format
Text format



Single Articles


    June 2019
  1. NAGAKUMAR P, Puttur F, Gregory LG, Denney L, et al
    Pulmonary type2 innate lymphoid cells in paediatric severe asthma: phenotype and response to steroids.
    Eur Respir J. 2019 Jun 4. pii: 13993003.01809-2018.
    PubMed     Text format     Abstract available


    May 2019
  2. SHOEMARK A, Cant E, Carreto L, Smith A, et al
    A point of care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation.
    Eur Respir J. 2019 May 31. pii: 13993003.00303-2019.
    PubMed     Text format     Abstract available


  3. RAVI A, Chowdhury S, Dijkhuis A, Bonta PI, et al
    Neutrophilic inflammation in asthma and defective epithelial translational control.
    Eur Respir J. 2019 May 20. pii: 13993003.00547-2019.
    PubMed     Text format     Abstract available


  4. VOGELBERG C, Szefler SJ, Vrijlandt EJLE, Boner AL, et al
    Tiotropium add-on therapy is safe and reduces seasonal worsenings in paediatric asthma patients.
    Eur Respir J. 2019 May 16. pii: 13993003.01824-2018.
    PubMed     Text format     Abstract available


  5. TOMMOLA M, Ilmarinen P, Tuomisto LE, Lehtimaki L, et al
    Cumulative effect of smoking on disease burden and multimorbidity in adult-onset asthma.
    Eur Respir J. 2019 May 2. pii: 13993003.01580-2018.
    PubMed     Text format    


  6. CHOI H, Yang B, Nam H, Kyoung DS, et al
    Population-based prevalence of bronchiectasis and associated comorbidities in South Korea.
    Eur Respir J. 2019 May 2. pii: 13993003.00194-2019.
    PubMed     Text format    


  7. HOLLEY S, Knibb R, Latter S, Liossi C, et al
    Development and validation of the Adolescent Asthma Self-Efficacy Questionnaire (AASEQ).
    Eur Respir J. 2019 May 2. pii: 13993003.01375-2018.
    PubMed     Text format     Abstract available


  8. O'BYRNE P, Fabbri LM, Pavord ID, Papi A, et al
    Asthma progression and mortality: The role of inhaled corticosteroids.
    Eur Respir J. 2019 May 2. pii: 13993003.00491-2019.
    PubMed     Text format     Abstract available


  9. MCBRIEN CN, Menzies-Gow A
    Less is more: the impact of maintenance treatment adherence in severe asthma clinical trials.
    Eur Respir J. 2019;53.
    PubMed     Text format    


  10. SCHLEICH F, Louis R
    It needs more than just eosinophils to cause emphysema in COPD.
    Eur Respir J. 2019;53.
    PubMed     Text format    


    April 2019
  11. PILLARISETTI N, Broderick D, Ainsworth A, Mulholland A, et al
    The airway microbiota in children newly diagnosed with bronchiectasis largely retains its diversity.
    Eur Respir J. 2019 Apr 25. pii: 13993003.00704-2019.
    PubMed     Text format    


  12. PEROTIN JM, Schofield JPR, Wilson SJ, Ward J, et al
    Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux.
    Eur Respir J. 2019 Apr 25. pii: 13993003.00453-2019.
    PubMed     Text format    


  13. HENKLE E, Curtis JR, Chen L, Chan B, et al
    Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis.
    Eur Respir J. 2019 Apr 18. pii: 13993003.01896-2018.
    PubMed     Text format     Abstract available


  14. TABEZE L, Marchand-Adam S, Borie R, Justet A, et al
    Severe asthma with blood hypereosinophilia associated with JAK2V617F mutation: a case series.
    Eur Respir J. 2019 Apr 18. pii: 13993003.02248-2018.
    PubMed     Text format    


  15. EFTHIMIOU J, Poll C, Barnes PJ
    Dual mechanism of action of T2 inhibitor therapies in virally induced exacerbations of asthma: evidence for a beneficial counter-regulation.
    Eur Respir J. 2019 Apr 18. pii: 13993003.02390-2018.
    PubMed     Text format     Abstract available


  16. LEHTO K, Pedersen NL, Almqvist C, Lu Y, et al
    Asthma and affective traits in adults: a genetically informative study.
    Eur Respir J. 2019 Apr 7. pii: 13993003.02142-2018.
    PubMed     Text format     Abstract available


  17. BEASLEY R, Bird G, Harper J, Weatherall M, et al
    Asthma paradoxes: time for a new approach across the spectrum of asthma severity.
    Eur Respir J. 2019;53.
    PubMed     Text format    


  18. NANNINI LJ
    Asthma paradoxes: time for a new approach across the spectrum of asthma severity.
    Eur Respir J. 2019;53.
    PubMed     Text format    


  19. MARTIN MJ, Harrison TW
    Is it time to move away from short-acting beta-agonists in asthma management?
    Eur Respir J. 2019;53.
    PubMed     Text format    


  20. BOUSQUET J
    Electronic clinical decision support system (eCDSS) in the management of asthma: from theory to practice.
    Eur Respir J. 2019;53.
    PubMed     Text format    


    March 2019
  21. JIANG Y, Gruzieva O, Wang T, Forno E, et al
    Transcriptomics of atopy and atopic asthma in white blood cells from children and adolescents.
    Eur Respir J. 2019 Mar 28. pii: 13993003.00102-2019.
    PubMed     Text format     Abstract available


  22. WANG J, Pindus M, Janson C, Sigsgaard T, et al
    Dampness, mould, onset and remission of adult respiratory symptoms, asthma and rhinitis.
    Eur Respir J. 2019 Mar 17. pii: 13993003.01921-2018.
    PubMed     Text format     Abstract available


  23. KUO CR, Lipworth B
    Differences in asthma control and lung function in relation to allergic status.
    Eur Respir J. 2019 Mar 17. pii: 13993003.02102-2018.
    PubMed     Text format    


  24. PAPAKONSTANTINOU E, Savic S, Siebeneichler A, Strobel W, et al
    A pilot study to test the feasibility of histological characterisation of asthma-COPD overlap.
    Eur Respir J. 2019 Mar 17. pii: 13993003.01941-2018.
    PubMed     Text format    


  25. SHAHEEN SO, Lundholm C, Brew BK, Almqvist C, et al
    Prescribed analgesics in pregnancy and risk of childhood asthma.
    Eur Respir J. 2019 Mar 17. pii: 13993003.01090-2018.
    PubMed     Text format     Abstract available


  26. MOKOKA MC, McDonnell MJ, MacHale E, Cushen B, et al
    Inadequate assessment of adherence to maintenance medication leads to loss of power and increased costs in trials of severe asthma therapy. Results from a systematic literature review and modelling study.
    Eur Respir J. 2019 Mar 7. pii: 13993003.02161-2018.
    PubMed     Text format     Abstract available


    February 2019
  27. BLOOM CI, Saglani S, Feary J, Jarvis D, et al
    Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population based cohort 2006-2016.
    Eur Respir J. 2019 Feb 14. pii: 13993003.02130-2018.
    PubMed     Text format     Abstract available


  28. DEN DEKKER HT, Burrows K, Felix JF, Salas LA, et al
    Newborn DNA-methylation, childhood lung function, and the risks of asthma and COPD across the life course.
    Eur Respir J. 2019 Feb 14. pii: 13993003.01795-2018.
    PubMed     Text format     Abstract available


  29. GUPTA S, Price C, Agarwal G, Chan D, et al
    The Electronic Asthma Management System (eAMS) Improves Primary Care Asthma Management.
    Eur Respir J. 2019 Feb 14. pii: 13993003.02241-2018.
    PubMed     Text format     Abstract available


  30. DOYLE AD, Mukherjee M, LeSuer WE, Bittner TB, et al
    Eosinophil-derived IL-13 Promotes Emphysema.
    Eur Respir J. 2019 Feb 6. pii: 13993003.01291-2018.
    PubMed     Text format     Abstract available


  31. NAIR P, O'Byrne PM
    The interleukin-13 paradox in asthma: effective biology, ineffective biologicals.
    Eur Respir J. 2019;53.
    PubMed     Text format    


  32. SHTEINBERG M, Shah A, Elborn JS
    New insights into immunological responses to infection in bronchiectasis.
    Eur Respir J. 2019;53.
    PubMed     Text format    


  33. PAHUS L, Jaffuel D, Vachier I, Bourdin A, et al
    Randomised controlled trials in severe asthma: selection by phenotype or stereotype.
    Eur Respir J. 2019;53.
    PubMed     Text format    


  34. GUAN WJ, Han XR, de la Rosa-Carrillo D, Martinez-Garcia MA, et al
    The significant global economic burden of bronchiectasis: a pending matter.
    Eur Respir J. 2019;53.
    PubMed     Text format    


    January 2019
  35. VAN DER MEER AN, de Jong K, Hoekstra-Kuik A, Bel EH, et al
    Dynamic hyperinflation impairs daily life activity in asthma.
    Eur Respir J. 2019 Jan 24. pii: 13993003.01500-2018.
    PubMed     Text format     Abstract available


  36. CHEN R, Zhang Q, Chen S, Tang H, et al
    IL-17F, rather than IL-17A, underlies airway inflammation in a steroid insensitive toluene diisocyanate-induced asthma model.
    Eur Respir J. 2019 Jan 17. pii: 13993003.01510-2018.
    PubMed     Text format     Abstract available


  37. COTTIN V, Azuma A, Raghu G, Stansen W, et al
    Therapeutic effects of nintedanib are not influenced by emphysema in the INPULSIS trials.
    Eur Respir J. 2019 Jan 17. pii: 13993003.01655-2018.
    PubMed     Text format    


  38. CRAMER N, Sedlacek L, Tummler B, Welte T, et al
    Low transmission risk of Pseudomonas aeruginosa in a bronchiectasis clinic based on the knowledge of bacterial population biology.
    Eur Respir J. 2019 Jan 11. pii: 13993003.02191-2018.
    PubMed     Text format    


  39. PIETERS A, Bakker M, Hoek RAS, Altenburg J, et al
    The clinical impact of pseudomonas aeruginosa eradication in bronchiectasis in a Dutch referral center.
    Eur Respir J. 2019 Jan 11. pii: 13993003.02081-2018.
    PubMed     Text format    


  40. ROTH M, Stolz D
    Biomarkers and personalised medicine for asthma.
    Eur Respir J. 2019;53.
    PubMed     Text format    


  41. METERSKY ML, ZuWallack RL
    Pulmonary rehabilitation for bronchiectasis: if not now, when?
    Eur Respir J. 2019;53.
    PubMed     Text format    


    December 2018
  42. TONGA KO, Berend N, Thamrin C, Farah CS, et al
    Lung elastic recoil and ventilation heterogeneity of diffusion-dependent airways in older people with asthma and fixed airflow obstruction.
    Eur Respir J. 2018 Dec 21. pii: 13993003.01028-2018.
    PubMed     Text format    


  43. PAVLIDIS S, Takahashi K, Kwong FNK, Xie J, et al
    "T2-high" in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin.
    Eur Respir J. 2018 Dec 21. pii: 13993003.00938-2018.
    PubMed     Text format     Abstract available


  44. PATEL S, Cole AD, Nolan CM, Barker RE, et al
    Pulmonary rehabilitation in bronchiectasis: a propensity matched study.
    Eur Respir J. 2018 Dec 21. pii: 13993003.01264-2018.
    PubMed     Text format     Abstract available


  45. DIEL R, Chalmers JD, Rabe KF, Nienhaus A, et al
    Economic burden of bronchiectasis in Germany.
    Eur Respir J. 2018 Dec 5. pii: 13993003.02033-2018.
    PubMed     Text format     Abstract available


    November 2018
  46. HANSEN AV, Ali Z, Malchau SS, Blafoss J, et al
    Fertility treatment among women with asthma - A case-control study of 3689 women with live births.
    Eur Respir J. 2018 Nov 21. pii: 13993003.00597-2018.
    PubMed     Text format     Abstract available


  47. TUOMISTO LE, Ilmarinen P, Lehtimaki L, Tommola M, et al
    Immediate bronchodilator response in FEV1 as a diagnostic criterion for adult asthma.
    Eur Respir J. 2018 Nov 21. pii: 13993003.00904-2018.
    PubMed     Text format     Abstract available


  48. SHRIMANKER R, Pavord ID, Yancey S, Heaney LG, et al
    Exacerbations of severe asthma in patients treated with Mepolizumab.
    Eur Respir J. 2018 Nov 21. pii: 13993003.01127-2018.
    PubMed     Text format    


  49. WELLS JM, Colangelo LA, Sivarajan L, Thyagarajan B, et al
    Inflammation and Endothelial Activation in Early Adulthood are Associated with Future Emphysema: The CARDIA Lung Study.
    Eur Respir J. 2018 Nov 21. pii: 13993003.01532-2018.
    PubMed     Text format    


  50. BUSSE WW, Brusselle GG, Korn S, Kuna P, et al
    Tralokinumab did not demonstrate oral corticosteroid-sparing effects in severe asthma.
    Eur Respir J. 2018 Nov 15. pii: 13993003.00948-2018.
    PubMed     Text format     Abstract available


  51. BEASLEY R, Bird G, Harper J, Weatherall M, et al
    The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity.
    Eur Respir J. 2018;52.
    PubMed     Text format    


  52. SKOPELJA-GARDNER S, Theprungsirikul J, Meagher RE, Beliveau CM, et al
    Autoimmunity to bactericidal/permeability-increasing protein in bronchiectasis exhibits a requirement for Pseudomonas aeruginosa IgG response.
    Eur Respir J. 2018 Nov 1. pii: 13993003.01891-2018.
    PubMed     Text format    


  53. ALIBERTI S, Polverino E, Chalmers JD, Altenburg J, et al
    The European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) ERS Clinical Research Collaboration.
    Eur Respir J. 2018;52.
    PubMed     Text format    


  54. DJUKANOVIC R, Adcock IM, Anderson G, Bel EH, et al
    The Severe Heterogeneous Asthma Research collaboration, Patient-centred (SHARP) ERS Clinical Research Collaboration: a new dawn in asthma research.
    Eur Respir J. 2018;52.
    PubMed     Text format    


    October 2018
  55. BROWN T, Jones T, Gove K, Barber C, et al
    Randomised Controlled Trials in Severe Asthma: Selection by Phenotype or Stereotype.
    Eur Respir J. 2018 Oct 25. pii: 13993003.01444-2018.
    PubMed     Text format     Abstract available


  56. RUSCONI F, Fernandes RM, Pijnenburg MWH, Grigg J, et al
    The Severe Paediatric Asthma Collaborative in Europe (SPACE) ERS Clinical Research Collaboration: enhancing participation of children with asthma in therapeutic trials of new biologics and receptor blockers.
    Eur Respir J. 2018;52.
    PubMed     Text format    


    September 2018
  57. CONTRERAS ZA, Chen Z, Roumeliotaki T, Annesi-Maesano I, et al
    Does early-onset asthma increase childhood obesity risk? A pooled analysis of 16 European cohorts.
    Eur Respir J. 2018 Sep 12. pii: 13993003.00504-2018.
    PubMed     Text format     Abstract available


  58. VOLMER T, Effenberger T, Trautner C, Buh R, et al
    Consequences of long-term OCS therapy and its side effects in severe asthma in adults - A focused review of the impact data in the literature.
    Eur Respir J. 2018 Sep 6. pii: 13993003.00703-2018.
    PubMed     Text format     Abstract available


  59. BOAVENTURA R, Sibila O, Agusti A, Chalmers JD, et al
    Treatable traits in bronchiectasis.
    Eur Respir J. 2018;52.
    PubMed     Text format    


  60. ARDURA-GARCIA C, Pedersen ESL, Goutaki M
    The limitations of cross-sectional data: perinatal risk factors for asthma.
    Eur Respir J. 2018;52.
    PubMed     Text format    


  61. ADLER D
    Bridging the gap in knowledge between dyspnoea scientists and clinicians.
    Eur Respir J. 2018;52.
    PubMed     Text format    


    August 2018
  62. BLEECKER ER, Wechsler ME, Mark FitzGerald J, Menzies-Gow A, et al
    Baseline Patient Factor Impact on the Clinical Efficacy of Benralizumab for Severe Asthma.
    Eur Respir J. 2018 Aug 23. pii: 13993003.00936-2018.
    PubMed     Text format     Abstract available


  63. GOSENS R, Gross N
    The mode of action of anticholinergics in asthma.
    Eur Respir J. 2018 Aug 16. pii: 13993003.01247-2017.
    PubMed     Text format     Abstract available


  64. WESTBERG AP, Salonen MK, von Bondsdorff M, Osmond C, et al
    Maternal adiposity in pregnancy and offspring asthma in adulthood.
    Eur Respir J. 2018 Aug 2. pii: 13993003.01152-2018.
    PubMed     Text format    


  65. MARTIN JG
    Airway smooth muscle may drive mucus hypersecretion in asthma.
    Eur Respir J. 2018;52.
    PubMed     Text format    


  66. CULVER BH
    Assessment of severity and prognosis in COPD: moving beyond percent of predicted.
    Eur Respir J. 2018;52.
    PubMed     Text format    


    July 2018
  67. AGARWAL R, Dhooria S, Singh Sehgal I, Aggarwal AN, et al
    A randomized trial of voriconazole and prednisolone monotherapy in acute-stage ABPA complicating asthma.
    Eur Respir J. 2018 Jul 26. pii: 13993003.01159-2018.
    PubMed     Text format    


  68. POLVERINO E, Dimakou K, Hurst J, Angel Martinez-Garcia M, et al
    The overlap between bronchiectasis and chronic airways diseases: state of the art and future directions.
    Eur Respir J. 2018 Jul 26. pii: 13993003.00328-2018.
    PubMed     Text format     Abstract available


  69. MES MA, Katzer CB, Chan AHY, Wileman V, et al
    Pharmacists and medication adherence in asthma: a systematic review and meta-analysis.
    Eur Respir J. 2018 Jul 5. pii: 13993003.00485-2018.
    PubMed     Text format     Abstract available


  70. ALLEN DJ, Holmes LJ, Hince KA, Daly R, et al
    Non-adherence with inhaled preventer therapy in severe asthmatic patients on long term Omalizumab.
    Eur Respir J. 2018 Jul 5. pii: 13993003.01025-2018.
    PubMed     Text format    


  71. ZHANG M, Litonjua AA, Mueller NT
    Maternal antibiotic use and child asthma: is the association causal?
    Eur Respir J. 2018;52.
    PubMed     Text format    


  72. ANDRIANASOLO RM, Kesse-Guyot E, Adjibade M, Hercberg S, et al
    Associations between dietary scores with asthma symptoms and asthma control in adults.
    Eur Respir J. 2018;52.
    PubMed     Text format     Abstract available



  73. "International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma." Kian Fan Chung, Sally E. Wenzel, Jan L. Brozek, Andrew Bush, Mario Castro, Peter J. Sterk, Ian M. Adcock, Eric D. Bateman, Elisabeth H. Bel, Eugene R. Bleecke
    Eur Respir J. 2018;52.
    PubMed     Text format    


  74. YOHANNES AM
    Serotonergic antidepressants in COPD: beneficial or harmful?
    Eur Respir J. 2018;52.
    PubMed     Text format    


  75. ERNST P
    Blood eosinophils in COPD and the future risk of pneumonia.
    Eur Respir J. 2018;52.
    PubMed     Text format    


    June 2018
  76. JANSON C, Lisspers K, Stallberg B, Johansson G, et al
    Prevalence, characteristics and management of frequently exacerbating asthma patients: an observational study in Sweden (PACEHR).
    Eur Respir J. 2018 Jun 25. pii: 13993003.01927-2017.
    PubMed     Text format     Abstract available


  77. FAIZ A, Weckmann M, Tasena H, Vermeulen CJ, et al
    Profiling of healthy and asthmatic airway smooth muscle cells following IL-1beta treatment: a novel role for CCL20 in chronic mucus hyper-secretion.
    Eur Respir J. 2018 Jun 25. pii: 13993003.00310-2018.
    PubMed     Text format     Abstract available


  78. GOEMINNE CP, Cox B, Finch S, Loebinger MR, et al
    The impact of acute air pollution fluctuations on bronchiectasis pulmonary exacerbation. A case-crossover analysis.
    Eur Respir J. 2018 Jun 14. pii: 13993003.02557-2017.
    PubMed     Text format     Abstract available


  79. MAC AOGAIN M, Chandrasekaran R, Lim Yick Hou A, Teck Boon L, et al
    IMMUNOLOGICAL COROLLARY OF THE PULMONARY MYCOBIOME IN BRONCHIECTASIS: THE CAMEB STUDY.
    Eur Respir J. 2018 Jun 7. pii: 13993003.00766-2018.
    PubMed     Text format     Abstract available


  80. RONIT A, Kristensen T, Hoseth VS, Abou-Kassem D, et al
    Computed tomography quantification of emphysema in people living with HIV and uninfected controls.
    Eur Respir J. 2018 Jun 7. pii: 13993003.00296-2018.
    PubMed     Text format     Abstract available


  81. GOMEZ REAL F, Burgess JA, Villani S, Dratva J, et al
    Maternal age at delivery, lung function and asthma in offspring: a population-based survey.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  82. SUGIYAMA T
    A multi-organ loss of tissue phenotype in COPD: involvement of the functional muscle-bone unit.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  83. RICCI F, Wollmer P, Engstrom G, Fedorowski A, et al
    Dysregulation of the "inflammatory reflex" with abnormal neurohumoral activation may contribute to proinflammatory activity driving the progression of COPD.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  84. ANDREAS S
    The association of cardiovascular autonomic dysfunction and the prediction of COPD can be explained by neurohumoral activation.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    May 2018
  85. DUFETELLE E, Bokov P, Delclaux C, Beydon N, et al
    Should reversibility be assessed in all asthmatic children with normal spirometry?
    Eur Respir J. 2018 May 31. pii: 13993003.00373-2018.
    PubMed     Text format    


  86. HYLAND ME, Jones RC, Lanario JW, Masoli M, et al
    The construction and validation of the Severe Asthma Questionnaire (SAQ).
    Eur Respir J. 2018 May 24. pii: 13993003.00618-2018.
    PubMed     Text format     Abstract available


  87. BIDAD N, Barnes N, Griffiths C, Horne R, et al
    UNDERSTANDING PATIENTS' PERCEPTIONS OF ASTHMA CONTROL: A QUALITATIVE STUDY.
    Eur Respir J. 2018 May 17. pii: 13993003.01346-2017.
    PubMed     Text format     Abstract available


  88. BURGE PS, Moore VC, Robertson AS, Walters GI, et al
    Do laboratory challenge tests for occupational asthma represent what happens in the workplace?
    Eur Respir J. 2018 May 10. pii: 13993003.00059-2018.
    PubMed     Text format     Abstract available


  89. BOURBEAU J, Farias R
    Making sense of telemedicine in the management of COPD.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  90. EKSTROM M, Elmberg V, Lindow T, Wollmer P, et al
    Breathlessness measurement should be standardised for the level of exertion.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  91. BUSSE WW
    Are peripheral blood eosinophil counts a guideline for omalizumab treatment? STELLAIR says no!
    Eur Respir J. 2018;51.
    PubMed     Text format    


  92. SCHEERENS C, Beernaert K, Pype P, Cohen J, et al
    Comparing the use and timing of palliative care services in COPD and lung cancer: a population-based survey.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    April 2018
  93. LOEWEN K, Monchka B, Mahmud SM, Jong G', et al
    Prenatal antibiotic exposure and childhood asthma: a population-based study.
    Eur Respir J. 2018 Apr 20. pii: 13993003.02070-2017.
    PubMed     Text format     Abstract available


  94. TSAI YH, Parker JS, Yang IV, Kelada SNP, et al
    Meta-Analysis of Airway Epithelia Gene Expression in Asthma.
    Eur Respir J. 2018 Apr 12. pii: 13993003.01962-2017.
    PubMed     Text format     Abstract available


  95. TAKAHASHI K, Pavlidis S, Ng Kee Kwong F, Hoda U, et al
    Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis.
    Eur Respir J. 2018 Apr 12. pii: 13993003.02173-2017.
    PubMed     Text format     Abstract available


  96. HAVET A, Zerimech F, Sanchez M, Siroux V, et al
    Outdoor air pollution, exhaled 8-isoprostane and current asthma in adults: the EGEA study.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  97. JOHNSON MJ, Yorke J, Hansen-Flaschen J, Ekstrom M, et al
    Chronic breathlessness: re-thinking the symptom.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  98. RAMOS HERNANDEZ C, Nunez Fernandez M, Mouronte-Roibas C, Mosteiro Anon M, et al
    HypAir FeNO: an electrochemical sensor.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    March 2018
  99. HANCOX RJ, Pavord ID, Sears MR
    Associations between blood eosinophils and decline in lung function among adults with and without asthma.
    Eur Respir J. 2018 Mar 21. pii: 13993003.02536-2017.
    PubMed     Text format     Abstract available


  100. HUMBERT M, Taille C, Mala L, Le Gros V, et al
    Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study.
    Eur Respir J. 2018 Mar 15. pii: 13993003.02523-2017.
    PubMed     Text format     Abstract available


  101. SHTEINBERG M, Stein N, Adir Y, Ken-Dror S, et al
    Prevalence, risk factors and prognosis of Non tuberculous mycobacteria infection among people with bronchiectasis: a population survey.
    Eur Respir J. 2018 Mar 15. pii: 13993003.02469-2017.
    PubMed     Text format    


  102. CHANOINE S, Sanchez M, Pin I, Temam S, et al
    Multimorbidity-medications and poor asthma prognosis.
    Eur Respir J. 2018 Mar 15. pii: 13993003.02114-2017.
    PubMed     Text format     Abstract available


  103. TO T, Feldman LY, Zhu J, Gershon AS, et al
    Asthma Health Services Utilization Before, During, and After Pregnancy: A Population-Based Cohort Study.
    Eur Respir J. 2018 Mar 8. pii: 13993003.00209-2018.
    PubMed     Text format     Abstract available


  104. LEE J, Ren Tay T, Radhakrishna N, Hore-Lacy F, et al
    Non-adherence in the era of severe asthma biologics and thermoplasty.
    Eur Respir J. 2018 Mar 8. pii: 13993003.01836-2017.
    PubMed     Text format     Abstract available


  105. DIJK FN, Xu C, Melen E, Carsin AE, et al
    Genetic regulation of IL1RL1 methylation and IL1RL1-a protein levels in asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  106. HESTER KLM, Newton J, Rapley T, Ryan V, et al
    Information and education provision in bronchiectasis: co-development and evaluation of a novel patient-driven resource in a digital era.
    Eur Respir J. 2018 Mar 1. pii: 13993003.02402-2017.
    PubMed     Text format    


  107. PATTINSON KTS, Rowland MJ, Nickol AH, Quinlan J, et al
    Adverse respiratory effects of opioids for chronic breathlessness: learning lessons from chronic pain.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    February 2018
  108. PERRY MM, Lavender P, Scott Kuo CH, Galea F, et al
    DNA methylation modules in airway smooth muscle are associated with asthma severity.
    Eur Respir J. 2018 Feb 15. pii: 13993003.01068-2017.
    PubMed     Text format    


  109. TURNER S, Fielding S, Devereux G
    First trimester fetal size and prescribed asthma medication at 15 years of age.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  110. NAGAKUMAR P, Gambir N, Sanghani N, Hall P, et al
    Role of a prolonged inpatient admission when evaluating children with problematic severe asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format    



  111. "Global strategy for asthma management and prevention: GINA executive summary." E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel a
    Eur Respir J. 2018;51.
    PubMed     Text format    


  112. MARTINEZ-GARCIA MA
    Pseudomonas aeruginosa infection and exacerbations in bronchiectasis: more questions than answers.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  113. ARAUJO D, Shteinberg M, Aliberti S, Goeminne PC, et al
    The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  114. LAVIGNE E, Belair MA, Rodriguez Duque D, Do MT, et al
    Effect modification of perinatal exposure to air pollution and childhood asthma incidence.
    Eur Respir J. 2018 Feb 1. pii: 13993003.01884-2017.
    PubMed     Text format     Abstract available


  115. SHAW D
    Putting the brake on accelerated lung function decline in asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  116. GRZESKOWIAK LE, Smithers LG, Grieger JA, Bianco-Miotto T, et al
    Asthma treatment impacts time to pregnancy: evidence from the international SCOPE study.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  117. COUMOU H, Westerhof GA, de Nijs SB, Zwinderman AH, et al
    Predictors of accelerated decline in lung function in adult-onset asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  118. CELLI BR, Locantore N, Tal-Singer R, Riley J, et al
    Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  119. PEKKANEN J, Valkonen M, Taubel M, Tischer C, et al
    Indoor bacteria and asthma in adults: a multicentre case-control study within ECRHS II.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  120. HACCURIA A, Van Muylem A, Malinovschi A, Doan V, et al
    Small airways dysfunction: the link between allergic rhinitis and allergic asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  121. SIMILOWSKI T
    Treat the lungs, fool the brain and appease the mind: towards holistic care of patients who suffer from chronic respiratory diseases.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  122. CRINER GJ
    Revising our approach to conducting therapeutic clinical research in COPD.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  123. HALPIN DMG
    Palliative care for people with COPD: effective but underused.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  124. SORIANO JB, Burgel PR
    On Don Quixote and pink puffers: multi-organ loss of tissue COPD.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  125. JONES R
    The scale of the problem of obstructive lung disease in Africa becomes clearer, but where are the solutions?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  126. SOHAL SS
    Inhaled corticosteroids and increased microbial load in COPD: potential role of epithelial adhesion molecules.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    January 2018
  127. MANISCALCO M, Paris D, Melck DJ, Molino A, et al
    Differential diagnosis between newly diagnosed asthma and chronic obstructive pulmonary disease using exhaled breath condensate metabolomics: a pilot study.
    Eur Respir J. 2018 Jan 18. pii: 13993003.01825-2017.
    PubMed     Text format    


  128. CHALMERS JD, Polverino E
    Macrolides, mucoactive drugs and adherence for the management of bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  129. GUAN WJ, Huang Y, Chen CL, Chen RC, et al
    Macrolides, mucoactive drugs and adherence for the management of bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  130. JORUP C, Lythgoe D, Bisgaard H
    Budesonide/formoterol maintenance and reliever therapy in adolescent patients with asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  131. SULAIMAN I, Greene G, MacHale E, Seheult J, et al
    A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  132. GAGA M, Samitas K, Zervas E
    Inhaler adherence in severe asthma: is there an electronic solution?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  133. TONG X, Wang D, Liu S, Ma Y, et al
    Can YKL-40 be used as a biomarker and therapeutic target for adult asthma?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  134. WONG C, Sullivan C, Jayaram L
    ELTGOL airway clearance in bronchiectasis: laying the bricks of evidence.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  135. CHALMERS JD, Ringshausen FC, Harris B, Elborn JS, et al
    Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  136. MUNOZ G, de Gracia J, Buxo M, Alvarez A, et al
    Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  137. CHOTIRMALL SH, Chalmers JD
    RESPIRE: breathing new life into bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  138. AKSAMIT T, De Soyza A, Bandel TJ, Criollo M, et al
    RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  139. DE SOYZA A, Aksamit T, Bandel TJ, Criollo M, et al
    RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  140. MACNAUGHTON J, Oxley R, Rose A, Russell A, et al
    Chronic breathlessness: re-thinking the symptom.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  141. JOHNSON MJ, Yorke J, Hansen-Flaschen J, Lansing R, et al
    Chronic breathlessness: re-thinking the symptom.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  142. AMBROSINO N
    Inspiratory muscle training in stable COPD patients: enough is enough?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  143. SPRUIT MA, Singh SJ, Rochester CL, Greening NJ, et al
    Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  144. FOWLER SJ
    Breath analysis for label-free characterisation of airways disease.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  145. WILSON KC, Krishnan JA, Sliwinski P, Criner GJ, et al
    Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  146. VANFLETEREN LEGW, Ullman A, Fabbri LM
    Time for a longer and better life for patients with COPD.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  147. BEASLEY R, Braithwaite I, Fingleton J, Weatherall M, et al
    The inhaled corticosteroid/long-acting beta-agonist maintenance and reliever therapy regimen: where to from here?
    Eur Respir J. 2018;51.
    PubMed     Text format    


  148. CLINI E, Castaniere I, Tonelli R
    Looking for a chronic care model in COPD patients.
    Eur Respir J. 2018;51.
    PubMed     Text format    


  149. SCHULTZ K, Jelusic D, Wittmann M, Kramer B, et al
    Inspiratory muscle training does not improve clinical outcomes in 3-week COPD rehabilitation: results from a randomised controlled trial.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  150. BEAUMONT M, Mialon P, Le Ber C, Le Mevel P, et al
    Effects of inspiratory muscle training on dyspnoea in severe COPD patients during pulmonary rehabilitation: controlled randomised trial.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  151. ALCAZAR-NAVARRETE B, Ruiz Rodriguez O, Conde Baena P, Romero Palacios PJ, et al
    Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  152. DE VRIES R, Dagelet YWF, Spoor P, Snoey E, et al
    Clinical and inflammatory phenotyping by breathomics in chronic airway diseases irrespective of the diagnostic label.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  153. KESSLER R, Casan-Clara P, Koehler D, Tognella S, et al
    COMET: a multicomponent home-based disease-management programme versus routine care in severe COPD.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  154. ROSE L, Istanboulian L, Carriere L, Thomas A, et al
    Program of Integrated Care for Patients with Chronic Obstructive Pulmonary Disease and Multiple Comorbidities (PIC COPD(+)): a randomised controlled trial.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


  155. STEURER-STEY C, Dalla Lana K, Braun J, Ter Riet G, et al
    Effects of the "Living well with COPD" intervention in primary care: a comparative study.
    Eur Respir J. 2018;51.
    PubMed     Text format     Abstract available


    December 2017
  156. KOURI A, Boulet LP, Kaplan A, Gupta S, et al
    Asthma control and action plans.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  157. BOUSQUET J, Brusselle G, Buhl R, Busse WW, et al
    Care pathways for the selection of a biologic in severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  158. AMIRAV I, Newhouse MT
    Asthma control and action plans.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  159. MORJARIA JB, Rigby AS, Morice AH
    Asthma phenotypes: do cough and wheeze predict exacerbations in persistent asthma?
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  160. ARAUJO D, Shteinberg M, Aliberti S, Goeminne PC, et al
    Standardised classification of the aetiology of bronchiectasis using an objective algorithm.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  161. SONG Y, Khoo SK, Lee KH, Makela M, et al
    Dual responses of CD14 methylation to distinct environments: a role in asthma and allergy.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  162. ANDRIANJAFIMASY M, Zerimech F, Akiki Z, Huyvaert H, et al
    Oxidative stress biomarkers and asthma characteristics in adults of the EGEA study.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  163. MCDONALD VM, Yorke J
    Adherence in severe asthma: time to get it right.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  164. DESLEE G, Leroy S, Perotin JM, Mal H, et al
    Two-year follow-up after endobronchial coil treatment in emphysema: results from the REVOLENS study.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  165. JOCHMANN A, Artusio L, Jamalzadeh A, Nagakumar P, et al
    Electronic monitoring of adherence to inhaled corticosteroids: an essential tool in identifying severe asthma in children.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    November 2017
  166. LIPWORTH BJ, Jabbal S
    Un-diagnosing persistent adult asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  167. SALEH AD, Kwok B, Brown JS, Hurst JR, et al
    Correlates and assessment of excess cardiovascular risk in bronchiectasis.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  168. KOLEVA PT, Tun HM, Konya T, Guttman DS, et al
    Sex-specific impact of asthma during pregnancy on infant gut microbiota.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  169. BOURDIN A, Molinari N, Vachier I, Pahus L, et al
    Mortality: a neglected outcome in OCS-treated severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format    


    October 2017
  170. VAN DEN WIJNGAART LS, Roukema J, Boehmer ALM, Brouwer ML, et al
    A virtual asthma clinic for children: fewer routine outpatient visits, same asthma control.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  171. DUMAS O, Wiley AS, Quinot C, Varraso R, et al
    Occupational exposure to disinfectants and asthma control in US nurses.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  172. VAN DEN WIJNGAART LS, Kievit W, Roukema J, Boehmer ALM, et al
    Online asthma management for children is cost-effective.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  173. GOMEZ JL, Yan X, Holm CT, Grant N, et al
    Characterisation of asthma subgroups associated with circulating YKL-40 levels.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available



  174. "Long-term outcomes of bronchial thermoplasty in subjects with severe asthma: a comparison of 3-year follow-up results from two prospective multicentre studies." Geoffrey Chupp, Michel Laviolette, Lauren Cohn, Charlene McEvoy, Sandeep Bansal, Adrian S
    Eur Respir J. 2017;50.
    PubMed     Text format    


  175. HEEDERIK D
    Occupational exposure and asthma control.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  176. BOWATTE G, Erbas B, Lodge CJ, Knibbs LD, et al
    Traffic-related air pollution exposure over a 5-year period is associated with increased risk of asthma and poor lung function in middle age.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


    September 2017
  177. BUSH A, Pavord ID
    After the asthmas: Star Wars and Star Trek.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  178. ROBINSON DS, Kariyawasam HH, Heaney LG
    Phase three studies of biologics for severe asthma: could do better?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  179. FRICKER M, Gibson PG
    Macrophage dysfunction in the pathogenesis and treatment of asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  180. TO T, Zhu J, Carlsten C, Larsen K, et al
    Do community demographics, environmental characteristics and access to care affect risks of developing ACOS and mortality in people with asthma?
    Eur Respir J. 2017;50.
    PubMed     Text format    


  181. O'BYRNE PM, Jenkins C, Bateman ED
    The paradoxes of asthma management: time for a new approach?
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  182. POLVERINO E, Goeminne PC, McDonnell MJ, Aliberti S, et al
    European Respiratory Society guidelines for the management of adult bronchiectasis.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  183. WENZEL SE, Brillhart S, Nowack K
    An invisible disease: severe asthma is more than just "bad asthma".
    Eur Respir J. 2017;50.
    PubMed     Text format    


  184. FOSTER JM, McDonald VM, Guo M, Reddel HK, et al
    "I have lost in every facet of my life": the hidden burden of severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available



  185. ERJ September Podcast: The hidden burden of severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format    


  186. HEKKING PP, Loza MJ, Pavlidis S, De Meulder B, et al
    Transcriptomic gene signatures associated with persistent airflow limitation in patients with severe asthma.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available


  187. CONRAD A, Janciauskiene S, Kohnlein T, Fuge J, et al
    Impact of alpha 1-antitrypsin deficiency and prior augmentation therapy on patients' survival after lung transplantation.
    Eur Respir J. 2017;50.
    PubMed     Text format    


    July 2017
  188. BOGAARD HJ
    Hypoxic pulmonary vasoconstriction in COPD-associated pulmonary hypertension: been there, done that?
    Eur Respir J. 2017;50.
    PubMed     Text format    


    June 2017
  189. SCHLAPBACH LJ, Straney L, Gelbart B, Alexander J, et al
    Burden of disease and change in practice in critically ill infants with bronchiolitis.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    May 2017
  190. COATES AL, Wanger J, Cockcroft DW, Culver BH, et al
    ERS technical standard on bronchial challenge testing: general considerations and performance of methacholine challenge tests.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    April 2017
  191. O'DONNELL DE, Casaburi R, Frith P, Kirsten A, et al
    Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  192. FANER R, Sibila O, Agusti A, Bernasconi E, et al
    The microbiome in respiratory medicine: current challenges and future perspectives.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  193. KNEIDINGER N, Milger K, Janitza S, Ceelen F, et al
    Lung volumes predict survival in patients with chronic lung allograft dysfunction.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    March 2017
  194. STOCKLEY JA, Ismail AM, Hughes SM, Edgar R, et al
    Maximal mid-expiratory flow detects early lung disease in alpha1-antitrypsin deficiency.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  195. LEDUC C, Antoni D, Charloux A, Falcoz PE, et al
    Comorbidities in the management of patients with lung cancer.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  196. PERSSON LJ, Aanerud M, Hardie JA, Miodini Nilsen R, et al
    Antimicrobial peptide levels are linked to airway inflammation, bacterial colonisation and exacerbations in chronic obstructive pulmonary disease.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  197. HUSEBO GR, Gronseth R, Lerner L, Gyuris J, et al
    Growth differentiation factor-15 is a predictor of important disease outcomes in patients with COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  198. WEDZICHA JA ERS CO-CHAIR, Miravitlles M, Hurst JR, Calverley PM, et al
    Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  199. NEDER JA, Berton DC, Arbex FF, Alencar MC, et al
    Physiological and clinical relevance of exercise ventilatory efficiency in COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  200. CROOK S, Busching G, Schultz K, Lehbert N, et al
    A multicentre validation of the 1-min sit-to-stand test in patients with COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  201. WILLIAMS MT, John D, Frith P
    Comparison of the Dyspnoea-12 and Multidimensional Dyspnoea Profile in people with COPD.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  202. VOGELMEIER CF, Criner GJ, Martinez FJ, Anzueto A, et al
    Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    February 2017
  203. LORX A, Czovek D, Gingl Z, Makan G, et al
    Airway dynamics in COPD patients by within-breath impedance tracking: effects of continuous positive airway pressure.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  204. MOLIMARD M, Raherison C, Lignot S, Balestra A, et al
    Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  205. LOWES D, Al-Shair K, Newton PJ, Morris J, et al
    Predictors of mortality in chronic pulmonary aspergillosis.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    January 2017
  206. KARIMI R, Tornling G, Forsslund H, Mikko M, et al
    Differences in regional air trapping in current smokers with normal spirometry.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  207. BENMERAD M, Slama R, Botturi K, Claustre J, et al
    Chronic effects of air pollution on lung function after lung transplantation in the Systems prediction of Chronic Lung Allograft Dysfunction (SysCLAD) study.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  208. KUNZ LI, Ten Hacken NH, Lapperre TS, Timens W, et al
    Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


  209. GREULICH T, Nell C, Hohmann D, Grebe M, et al
    The prevalence of diagnosed alpha1-antitrypsin deficiency and its comorbidities: results from a large population-based database.
    Eur Respir J. 2017;49.
    PubMed     Text format     Abstract available


    November 2016
  210. HASEGAWA K, Mansbach JM, Ajami NJ, Espinola JA, et al
    Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis.
    Eur Respir J. 2016;48:1329-1339.
    PubMed     Text format     Abstract available


    April 2016
  211. HOFFMANN J, Wilhelm J, Olschewski A, Kwapiszewska G, et al
    Microarray analysis in pulmonary hypertension.
    Eur Respir J. 2016 Apr 13. pii: ERJ-02030-2015. doi: 10.1183/13993003.02030-2015
    PubMed     Text format     Abstract available


    March 2016
  212. MILARA J, Escriva J, Ortiz JL, Juan G, et al
    Vascular effects of sildenafil in patients with pulmonary fibrosis and pulmonary hypertension: an ex vivo/in vitro study.
    Eur Respir J. 2016 Mar 23. pii: ERJ-01259-2015. doi: 10.1183/13993003.01259-2015
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: